These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 14586729)
1. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet. Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729 [TBL] [Abstract][Full Text] [Related]
2. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake. Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730 [TBL] [Abstract][Full Text] [Related]
3. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease. Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure. Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424 [TBL] [Abstract][Full Text] [Related]
5. [The effect of a low-protein diet and certain pharmaceutical agents on the course of ablation nephropathy in rats]. Heller J; Cervenka L; Hellerová S Cas Lek Cesk; 1994 Jul; 133(14):429-33. PubMed ID: 8069900 [TBL] [Abstract][Full Text] [Related]
6. [Effect of oral adsorbent (AST-120) in the rat model of chronic renal failure induced by adriamycin]. Yoshida Y; Ise M Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1055-9. PubMed ID: 1289605 [TBL] [Abstract][Full Text] [Related]
7. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure. Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effects of a low protein diet and angiotensin converting enzyme inhibitors on renal insufficiency in hypertensive rats]. Cervenka L; Heller J Cas Lek Cesk; 1996 May; 135(10):305-7. PubMed ID: 8697492 [TBL] [Abstract][Full Text] [Related]
9. [Pathological study on the effect of oral adsorbent AST-120 on chronic renal failure in rats]. Kuwao S; Sakai T; Kumano K; Ise M; Uehara Y Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):731-41. PubMed ID: 1770633 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats. Aoyama I; Shimokata K; Niwa T Nephron; 2002 Mar; 90(3):297-312. PubMed ID: 11867951 [TBL] [Abstract][Full Text] [Related]
11. Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation. Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamagishi S Metabolism; 2011 Feb; 60(2):260-4. PubMed ID: 20189611 [TBL] [Abstract][Full Text] [Related]
12. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Owada A; Nakao M; Koike J; Ujiie K; Tomita K; Shiigai T Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455 [TBL] [Abstract][Full Text] [Related]
13. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy. Namikoshi T; Tomita N; Satoh M; Sakuta T; Kuwabara A; Kobayashi S; Higuchi Y; Nishijima F; Kashihara N Hypertens Res; 2009 Mar; 32(3):194-200. PubMed ID: 19262482 [TBL] [Abstract][Full Text] [Related]
14. [Effect of oral-adsorbent (AST-120) in chronic renal failure (CRF) in rats]. Sakai T; Kumano K; Takara S; Kuwao S; Ise M; Sugano M; Uehara Y Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):359-65. PubMed ID: 2747009 [TBL] [Abstract][Full Text] [Related]
15. Correction by oral adsorbent of abnormal digestive tract milieu in rats with chronic renal failure. Okada K; Takahashi S Nephrol Dial Transplant; 1995; 10(5):671-6. PubMed ID: 7566581 [TBL] [Abstract][Full Text] [Related]
16. [Effect of oral adsorbent AST-120 in rats with chronic renal failure--mechanism of progression of renal failure by dietary protein]. Niimura F; Ise M; Uehara Y; Kumano K; Sakai T Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):261-71. PubMed ID: 1630028 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy. Sanaka T; Akizawa T; Koide K; Koshikawa S Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877 [TBL] [Abstract][Full Text] [Related]
18. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats. Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258 [TBL] [Abstract][Full Text] [Related]
19. [Effect of oral adsorbent AST-120 under standard treatment of care in patients with chronic renal failure]. Yoshida I; Komada T; Sakuma Y; Mori H; Funayama I; Tabei K Nihon Jinzo Gakkai Shi; 2009; 51(2):121-9. PubMed ID: 19378798 [TBL] [Abstract][Full Text] [Related]
20. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]